In the following video, Motley Fool health-care analyst David Williamson highlights one critical asset for pharmaceutical company Celgene (CELG +0.00%) -- its management. He gives investors three factors that he sees as essential for the leader of any pharmaceutical company, and tells us how well Celgene's Chairman and CEO Bob Hugin stacks up to those criteria.
Why Celgene's Management Is a Strength
By Dave Williamson – Mar 22, 2013 at 7:13PM
NASDAQ: CELG
Celgene
Why Celgene's top brass is a big asset.
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Follow @motleydavid